Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|29|3797-3804

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.29, 2009-01, pp. : 3797-3804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 275-287

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the epidermal growth factor receptor in solid tumors: focus on safety

By Lucchini Eleonora   Pilotto Sara   Spada Elisa   Melisi Davide   Bria Emilio   Tortora Giampaolo  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 535-549

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targeting of G-Protein Coupled Receptor-Mediated Epidermal Growth Factor Receptor Transactivation in Human Glioma Brain Tumors

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-11 ,pp. : 1418-1428

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor Family in Radionuclide Therapy of Tumors-Signal Transduction and DNA Repair

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 6, 2006-08 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite